[1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385-427.10.1146/annurev.bi.62.070193.002125]Open DOISearch in Google Scholar
[2. Persidis A. Cancer multidrug resistance. Nat Biotechnol. 1999; 17:94-5.10.1038/5289]Open DOISearch in Google Scholar
[3. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987; 84:265-9.10.1073/pnas.84.1.265]Open DOISearch in Google Scholar
[4. Callaghan R, Crowley E, Potter S, Kerr ID. P-glycoprotein: so many ways to turn it on. J Clin Pharmacol. 2008; 48:365-78.10.1177/0091270007311568]Open DOISearch in Google Scholar
[5. Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008; 60:196-209.10.1124/pr.107.07109]Open DOISearch in Google Scholar
[6. Sein KK, Maeno Y, Thuc HV, Anh TK, Aikawa M. Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg. 1993; 48:504-11.10.4269/ajtmh.1993.48.504]Search in Google Scholar
[7. Kochar DK, Kumawat BL, Halwai M, Kochar SK, Shubhakaran, Thanvi I. Brainstem auditory evoked potentials and somatosensory evoked potentials in cerebral malaria-a prognostic significance. J Assoc Physicians India. 2000; 48:295-300.]Search in Google Scholar
[8. Chaudhary HR, Meena SR, Jani D, Tiwari U, Goyal RK. Extrapyramidal syndrome in cerebral malaria. J Assoc Physicians India. 1992; 40:347.]Search in Google Scholar
[9. Clark CJ, Phillips RS, Stone TW. Neuropeptidecontaining cells in the cortex and striatum of mice with cerebral malaria. Adv Exp Med Biol. 2003; 527: 347-52.10.1007/978-1-4615-0135-0_38]Search in Google Scholar
[10. Newton CR, Warrell DA. Neurological manifestations of falciparum malaria. Ann Neurol. 1998; 43:695-702.10.1002/ana.410430603]Open DOISearch in Google Scholar
[11. Berendt AR, Tumer GD, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994; 10:412-4.10.1016/0169-4758(94)90238-0]Open DOISearch in Google Scholar
[12. Brown H, Turner G, Rogerson S, Tembo M, Mwenechanya J, Molyneux M, et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis. 1999; 180:1742-6.10.1086/31507810515846]Search in Google Scholar
[13. Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999; 25:331-40.10.1046/j.1365-2990.1999.00188.x]Open DOISearch in Google Scholar
[14. Abbott NJ, Hughes CC, Revest PA, Greenwood J. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci. 1992; 103:23-37.10.1242/jcs.103.1.23]Search in Google Scholar
[15. Hong H, Lu Y, Ji ZN, Liu GQ. Up-regulation of P-glycoprotein expression by glutathione depletioninduced oxidative stress in rat brain microvessel endothelial cells. J Neurochem. 2006; 98:1465-73.10.1111/j.1471-4159.2006.03993.x]Open DOISearch in Google Scholar
[16. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, et al. The neuropathology of fatal cerebral malaria in Malawian children. Am J Pathol. 2011; 178:2146-58.10.1016/j.ajpath.2011.01.016]Search in Google Scholar
[17. Idro R, Kakooza-Mwesige A, Balyejjussa S, Mirembe G, Mugasha C, Tugumisirize J, et al. Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes. 2010; 3:104.10.1186/1756-0500-3-104]Open DOISearch in Google Scholar
[18. Kooij G, van Horssen J, de Lange EC, Reijerkerk A, van der Pol SM, van Het Hof B, et al. T lymphocytes impair P-glycoprotein function during neuroinflammation. J Autoimmun. 2010; 34:416-25.10.1016/j.jaut.2009.10.006]Open DOISearch in Google Scholar
[19. McRae MP, Brouwer KL, Kashuba AD. Cytokine regulation of P-glycoprotein. Drug Metab Rev. 2003; 35:19-33.10.1081/DMR-120018247]Open DOISearch in Google Scholar
[20. Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol. 2003; 139: 35-48.10.1038/sj.bjp.0705227]Search in Google Scholar
[21. Zhao YL, Du J, Kanazawa H, Sugawara A, Takagi K, Kitaichi K, et al. Effect of endotoxin on doxorubicin transport across blood-brain barrier and Pglycoprotein function in mice. Eur J Pharmacol. 2002; 445:115-23.10.1016/S0014-2999(02)01661-8]Search in Google Scholar
[22. Tan KH, Purcell WM, Heales SJ, McLeod JD, Hurst RD. Evaluation of the role of P-glycoprotein in inflammation induced blood-brain barrier damage. Neuroreport. 2002; 13:2593-7.10.1097/00001756-200212200-0004212499874]Open DOISearch in Google Scholar
[23. Theron D, Barraud de Lagerie S, Tardivel S, Pelerin H, Demeuse P, Mercier C, et al. Influence of tumor necrosis factor-á on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem Pharmacol. 2003; 66:579-87.10.1016/S0006-2952(03)00340-X]Open DOISearch in Google Scholar
[24. Walther W, Stein U. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J Cancer Res Clin Oncol. 1994; 120:471-8.10.1007/BF011918008207045]Open DOISearch in Google Scholar
[25. Yu C, Kastin AJ, Tu H, Waters S, Pan W. TNF activates P-glycoprotein in cerebral microvascular endothelial cells. Cell Physiol Biochem. 2007; 20:853-8.10.1159/00011044517982267]Open DOISearch in Google Scholar
[26. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SM, et al. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One. 2009; 4:e8212. 10.1371/journal.pone.0008212278547919997559]Open DOISearch in Google Scholar